Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan.
Department of Medical Imaging, National Taiwan University Hospital Yun-Lin Branch, Yunlin, Taiwan.
Jpn J Radiol. 2024 Aug;42(8):852-861. doi: 10.1007/s11604-024-01570-y. Epub 2024 May 6.
Mycobacterium abscessus complex (MABC) commonly causes lung disease (LD) and has a high treatment failure rate of around 50%. In this study, our objective is to investigate specific CT patterns for predicting treatment prognosis and monitoring treatment response, thus providing valuable insights for clinical physicians in the management of MABC-LD treatment.
We retrospectively assessed 34 patients with MABC-LD treated between January 2015 and December 2020. CT scores for bronchiectasis, cellular bronchiolitis, consolidation, cavities, and nodules were measured at initiation and after treatment. The ability of the CT scores to predict treatment outcomes was analyzed in logistic regression analyses.
The CT scoring system had excellent inter-reader agreement (all intraclass correlation coefficients, > 0.82). The treatment failure (TF) group (17/34; 50%) had higher cavitation diameter (p = 0.049) and extension (p = 0.041) at initial CT and higher cavitation diameter (p = 0.049) and extension (p =0 .045), consolidation (p = 0.022), and total (p = 0.013) scores at follow-up CT than the treatment success (TS) group. The changes of total score and consolidation score (p = 0.049 and 0.024, respectively) increased in the TF group more than the TS group between the initial and follow-up CT. Multivariable logistic regression analysis showed initial cavitation extension, follow-up consolidation extension, and change in consolidation extension (adjusted odds ratio: 2.512, 2.495, and 9.094, respectively, per 1-point increase; all p < 0.05) were significant predictors of treatment failure.
A high pre-treatment cavitation extension score and an increase in the consolidation extension score during treatment on CT could be alarm signs of treatment failure requiring tailor the treatment of MABC-LD carefully.
脓肿分枝杆菌复合体(MABC)通常会引起肺部疾病(LD),其治疗失败率约为 50%。本研究旨在探讨特定 CT 模式预测治疗预后和监测治疗反应的能力,为临床医生管理 MABC-LD 治疗提供有价值的见解。
我们回顾性评估了 2015 年 1 月至 2020 年 12 月期间接受治疗的 34 例 MABC-LD 患者。在开始治疗和治疗后,测量支气管扩张、细胞性细支气管炎、实变、空洞和结节的 CT 评分。采用逻辑回归分析评估 CT 评分预测治疗结局的能力。
该 CT 评分系统具有良好的读者间一致性(所有组内相关系数,均>0.82)。治疗失败(TF)组(17/34;50%)在初始 CT 时具有更大的空洞直径(p=0.049)和扩展(p=0.041),在随访 CT 时具有更大的空洞直径(p=0.049)和扩展(p=0.045)、实变(p=0.022)和总分(p=0.013)。TF 组在初始 CT 与随访 CT 之间,总分和实变评分的变化(p=0.049 和 0.024)比 TS 组增加更多。多变量逻辑回归分析显示,初始空洞扩展、随访时的实变扩展以及实变扩展的变化(调整优势比:2.512、2.495 和 9.094,每增加 1 分;均 p<0.05)是治疗失败的显著预测因素。
治疗前空洞扩展评分高,治疗期间 CT 上实变扩展评分增加可能是治疗失败的预警信号,需要仔细调整 MABC-LD 的治疗方案。